U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA ...
Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of Allowance received ...
Significant immune responses observed in 100% of Zika-vaccinated subjects and 98% of MERS-vaccinated human ...
